BlackRock Investment Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	$847K	Buy	77,074 +495	+0.6%	+$5.44K	﹤0.01%	2780
2016 Q3	$1.2M	Sell	76,579 -131	-0.2%	-$2.05K	﹤0.01%	2533
2016 Q2	$784K	Buy	76,710 +49,279	+180%	+$504K	﹤0.01%	2789
2016 Q1	$354K	Buy	27,431 +664	+2%	+$8.57K	﹤0.01%	3012
2015 Q4	$559K	Buy	+26,767	New	+$559K	﹤0.01%	2952